Domperidone - CAS 57808-66-9
Catalog number: 57808-66-9
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C22H24ClN5O2
Molecular Weight:
425.91
COA:
Inquire
Targets:
Dopamine Receptor
Description:
Domperidone is a medication developed by Janssen Pharmaceutica that acts as a peripherally-selective antagonist of the dopamine D2 and D3 receptors.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
MSDS:
Inquire
1.Drugs with potential cardiac adverse effects: Retrospective study in a large cohort of parkinsonian patients.
Heranval A1, Lefaucheur R1, Fetter D1, Rouillé A1, Le Goff F1, Maltête D2. Rev Neurol (Paris). 2016 Apr 7. pii: S0035-3787(16)00431-8. doi: 10.1016/j.neurol.2015.11.007. [Epub ahead of print]
INTRODUCTION/OBJECTIVE: Drugs with potential cardiac adverse effects are commonly prescribed in Parkinson's disease (PD). To describe demographic and clinical characteristics in a group of PD patients with cardiac events and to evaluate risk factors.
2.Formulation development and evaluation of medicated chewing gum of anti-emetic drug.
Paradkar M1, Gajra B1, Patel B2. Saudi Pharm J. 2016 Mar;24(2):153-64. doi: 10.1016/j.jsps.2015.02.017. Epub 2015 Apr 3.
CONTEXT: Medicated chewing gum (MCG) of Domperidone Maleate (DM) was developed by direct compression method with the goal to achieve quick onset of action and to improve patient compliance.
3.Characteristics and Functional Roles of Opioids Originally Present in Vivo.
Ozaki M1. Yakugaku Zasshi. 2016;136(4):591-605. doi: 10.1248/yakushi.15-00265.
The characteristics and functional roles of opioids originally present in vivo (endogenous opioids) in guinea-pig ileum were investigated. The release of endogenous opioids was determined by the inhibitory twitch response evoked by 0.1 Hz stimulation after 10 Hz stimulation (post-tetanic twitch inhibition). The effects of peptidase inhibitors increased the post-tetanic twitch inhibition, prevented by β-funaltrexamine and nor-binaltorphimine, which are selective μ- and κ-opioid receptor subtype antagonists, respectively. Dopamine receptor antagonists (haloperidol, sultopride and domperidone) increased the post-tetanic twitch inhibition. These results suggest that dopamine receptors are involved in modulation of the ileal opioid system, so as to diminish endogenous opioid release by tetanic stimulation, and dopamine antagonists increase the opioid action, that might depend more on the increased release of endogenous opioids. The post-tetanic twitch inhibition was inhibited by adrenalectomy, and showed the supersensitivity of the opioid receptors, resulting from a decrease of endogenous opioids by adrenalectomy.
4.Effects of the fish spawning inducer ovaprim on vasotocin receptor gene expression in brain and ovary of the catfish Heteropneustes fossilis with a note on differential transcript expression in ovarian follicles.
Rawat A1, Chaube R1, Joy KP2. Gen Comp Endocrinol. 2016 Mar 7. pii: S0016-6480(16)30046-6. doi: 10.1016/j.ygcen.2016.03.002. [Epub ahead of print]
Ovaprim (OVP), a commercial formulation of a salmon GnRH analogue and the dopamine receptor-2 blocker domperidone, is a successful spawning inducer for fish breeding. It induces a preovulatory surge in LH, which stimulates the synthesis of a maturation-inducing steroid (MIS, 17,20β-dihydroxy-4-pregnen-3-one) that initiates germinal vesicle breakdown (GVBD) and ovulation. Coincidently, the OVP treatment also stimulates vasotocin (VT) secretion in the brain and ovary of the catfish Heteropneustes fossilis that also stimulates the synthesis of the MIS. VT mediates its effect through V1- and V2-type receptors. In the present study in the catfish, we report that OVP stimulates the expression of VT receptor genes v1a1, v1a2 and v2a in the brain and ovary. A single intraperitoneal administration of OVP (0.5μL/g body weight) or incubation of post-vitellogenic ovarian follicles with 5μL/mL OVP, for 0, 4, 8, 12, 16, and 24h stimulated ovulation and GVBD, respectively, in a time-dependent manner.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Dopamine Receptor Products


CAS 146939-27-7 Ziprasidone

Ziprasidone
(CAS: 146939-27-7)

Ziprasidone is a combined 5-HT (serotonin) and dopamine receptor antagonist like other atypical antipsychotic agents. Ziprasidone targets dopamine neurotransmis...

CAS 548-73-2 Droperidol

Droperidol
(CAS: 548-73-2)

Droperidol is a potent antagonist of dopamine subtype 2 receptors in the limbic system.

CAS 24526-64-5 Nomifensine

Nomifensine
(CAS: 24526-64-5)

Nomifensine, also called as Hoe 984 or Linamiphen, as a norepinephrine-dopamine reuptake inhibitor it is an antidepressant drug but due to increased incidence o...

CAS 170381-16-5 Zicronapine

Zicronapine
(CAS: 170381-16-5)

Zicronapine, an inden derivative, has been found to be neurotransmitter receptor modulators of sorts of neurotransmitter and was studied against Schizophrenia.

CAS 1649-18-9 Azaperone

Azaperone
(CAS: 1649-18-9)

Azaperone is a pyridinylpiperazine and butyrophenone neuroleptic drug with sedative and antiemetic effects, which is used mainly as a tranquilizer in veterinary...

CAS 51012-33-0 Tiapride hydrochloride

Tiapride hydrochloride
(CAS: 51012-33-0)

Tiapride is a D2 and D3 dopamine receptor antagonist used to treat a variety of neurological and psychiatric disorders.

ABT670
(CAS: 630119-43-6)

ABT670 is a drug which acts as a potent, superior orally bioavailable dopamine agonist selective for the D4 subtype. It was used as a possible treatment for ere...

CAS 67227-57-0 Fenoldopam Mesylate

Fenoldopam Mesylate
(CAS: 67227-57-0)

Fenoldopam is a selective D1 receptor partial agonist, binds to α2-adrenoceptors, increasing renal blood flow used as an antihypertensive agent.

Vanoxerine
(CAS: 67469-69-9)

Vanoxerin is a dopamine uptake inhibitor. It is potentially used for the treatment of atrial fibrillation.

CAS 104632-28-2 Dexpramipexole

Dexpramipexole
(CAS: 104632-28-2)

Dexpramipexole, also known as R-(+)-Pramipexole, is one of the impurities of pramipexole(USP D). It coule be used as a negative control in the research of dopam...

Amisulpride hydrochloride
(CAS: 81342-13-4)

Amisulpride hydrochloride could inhibit radioligand binding to native dopamine D2 receptor in membranes from the rat striatum with an IC50 value of 21nM. It has...

Aplindore Fumarate
(CAS: 189681-71-8)

Aplindore Fumarate is a partial agonist selective for the dopamine receptor D2 used in the therapeutic treatment of Parkinson Disease and restless legs syndrome...

CAS 125572-93-2 Rotigotine Hydrochloride

Rotigotine Hydrochloride
(CAS: 125572-93-2)

The hydrochloride salt form of Rotigotine which is a dopamine D2 and D3 receptor agonist and has been shown to be effective in the treatment of Parkinson's dise...

CAS 53772-83-1 Zuclopenthixol

Zuclopenthixol
(CAS: 53772-83-1)

Zuclopenthixol is an antagonist at D1 and D2 dopamine receptors. It also has high affinity for alpha1-adrenergic and 5-HT2 receptors, but it has weaker histamin...

CAS 84226-12-0 Eticlopride

Eticlopride
(CAS: 84226-12-0)

Eticlopride is a selective dopamine D2 antagonist . It was initially developed as a potential antipsychotic agent. Now Eticlopride is primarily used in pharmaco...

PD-118717
(CAS: 104229-37-0)

PD-118717 is a putative piperazinyl benzopyranone dopamine autoreceptor(DA) agonist. It has the profile of a DA autoreceptor agonist in neurochemical and neurop...

CAS 113-59-7 Chlorprothixene

Chlorprothixene
(CAS: 113-59-7)

Chlorprothixene has strong binding affinities to dopamine and histamine receptors, such as D1, D2, D3, D5, H1, 5-HT2, 5-HT6 and 5-HT7, with Ki of 18 nM, 2.96 nM...

CAS 839712-12-8 Cariprazine

Cariprazine
(CAS: 839712-12-8)

Cariprazine is an orally active D2/D3 dopamine receptor antagonist exhibits high selectivity and affinity to dopamine D3(Ki=0.09 nM) and D2 (Ki=0.5 nM) receptor...

CAS 53583-79-2 Barnetil

Barnetil
(CAS: 53583-79-2)

Barnetil acts as a selective D2 and D3 receptor antagonist, which has high affinity for these receptors of dissociation constants of 2.2 nM and 2.4 nM respectiv...

CAS 66644-81-3 Veralipride

Veralipride
(CAS: 66644-81-3)

Veralipride is a D2 receptor antagonist in the hypothalamic system and has a half-life of approximately 12 hours. Veralipride is highly active on the neurotrans...

Chemical Structure

CAS 57808-66-9 Domperidone

Quick Inquiry

Verification code

Featured Items